BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11206902)

  • 1. Axillary lymph node status of T1 primary breast cancer in a diverse population.
    Madan AK; Macareo L; Winfrey K; Beech DJ
    Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary lymph node dissection in breast cancer: an evolving question?
    Lagares-Garcia JA; Garguilo G; Kurek S; LeBlond G; Diaz F
    Am Surg; 2000 Jan; 66(1):66-72. PubMed ID: 10651351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T1a and T1b breast cancer: a twelve-year experience.
    Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P
    Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary lymph node dissection: does it have a role in primary breast cancer?
    Pack MS; Thomas RS
    Am Surg; 1996 Feb; 62(2):159-61. PubMed ID: 8554194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
    Saidi RF; Dudrick PS; Remine SG; Mittal VK
    Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.
    Giuliano AE; Barth AM; Spivack B; Beitsch PD; Evans SW
    J Am Coll Surg; 1996 Sep; 183(3):185-9. PubMed ID: 8784309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting axillary lymph node metastases in patients with T1 breast carcinoma.
    Markopoulos C; Kouskos E; Gogas H; Mandas D; Kakisis J; Gogas J
    Am Surg; 2000 Nov; 66(11):1011-3. PubMed ID: 11090007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel lymph node biopsy in breast cancer].
    Shen K; Nirmal L; Han Q; Wu J; Lu J; Zhang J; Liu G; Shao Z; Shen Z
    Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):347-50. PubMed ID: 12133338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of axillary lymph node metastasis in T1 breast carcinoma.
    Shoup M; Malinzak L; Weisenberger J; Aranha GV
    Am Surg; 1999 Aug; 65(8):748-52; discussion 752-3. PubMed ID: 10432085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
    Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
    Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer.
    Barone JE; Tucker JB; Perez JM; Odom SR; Ghevariya V
    Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of sentinel node biopsy in the previously treated breast.
    Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
    Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC; Fey JV; Borgen PI; Cody HS
    J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.